Sancti Spíritus Biotechnology contributes to a Vaccine Candidate against Dengue

The Center for Genetic Engineering and Biotechnology, CIGB, in Sancti Spiritus, has accumulated experience in the development, generation, production and commercialization of monoclonal antibodies, their conjugates and recombinant proteins. One of its researchers is a member of the team working on obtaining a vaccine candidate against dengue.